open access

Vol 14, No 5 (2019)
Electrotherapy
Published online: 2019-10-31
Get Citation

Methods of preventing phrenic nerve stimulation in patients with cardiac resynchronisation therapy

Tomasz Wcisło, Jarosław D. Kasprzak
DOI: 10.5603/FC.2019.0104
·
Folia Cardiologica 2019;14(5):522-526.

open access

Vol 14, No 5 (2019)
Electrotherapy
Published online: 2019-10-31

Abstract

Cardiac resynchronisation therapy is an established therapy for patients with advanced heart failure, decreased left ventricular ejection fraction, a wide QRS syndrome, and the presence of left ventricular dyssynchrony despite optimal pharmacotherapy. The key feature for applied treatment is proper qualification and the optimal placing of left ventricular electrode implantation. The major issues that limit resynchronisation therapy are high left ventricle pacing threshold and phrenic nerve stimulation (PNS). PNS occurs in 30% of patients at implantation. In this paper, we present alternative methods of avoiding PNS based on the latest clinical trials and our own experience.

Abstract

Cardiac resynchronisation therapy is an established therapy for patients with advanced heart failure, decreased left ventricular ejection fraction, a wide QRS syndrome, and the presence of left ventricular dyssynchrony despite optimal pharmacotherapy. The key feature for applied treatment is proper qualification and the optimal placing of left ventricular electrode implantation. The major issues that limit resynchronisation therapy are high left ventricle pacing threshold and phrenic nerve stimulation (PNS). PNS occurs in 30% of patients at implantation. In this paper, we present alternative methods of avoiding PNS based on the latest clinical trials and our own experience.

Get Citation

Keywords

cardiac resynchronisation therapy, heart failure, phrenic nerve stimulation (PNS)

About this article
Title

Methods of preventing phrenic nerve stimulation in patients with cardiac resynchronisation therapy

Journal

Folia Cardiologica

Issue

Vol 14, No 5 (2019)

Pages

522-526

Published online

2019-10-31

DOI

10.5603/FC.2019.0104

Bibliographic record

Folia Cardiologica 2019;14(5):522-526.

Keywords

cardiac resynchronisation therapy
heart failure
phrenic nerve stimulation (PNS)

Authors

Tomasz Wcisło
Jarosław D. Kasprzak

References (15)
  1. Karasek D, Kubica A, Sinkiewicz W. Epidemia niewydolności serca — problem zdrowotny i społeczny starzejących się społeczeństw Polski i Europy. Folia Cardiol Excerpta. 2008; 3: 242–8.
  2. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  3. Bristow MR, Saxon L, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med . 2004; 350(21): 2140–2150.
  4. Cleland JGF, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352(15): 1539–1549.
  5. Ansalone G, Giannantoni P, Ricci R, et al. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol. 2002; 39(3): 489–499.
  6. Lambiase PD, Rinaldi A, Hauck J, et al. Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy. Heart. 2004; 90(1): 44–51.
  7. Sterliński M, Maciag A, Kowalik I, et al. Success rate of transvenous left ventricular lead implantation for cardiac resynchronisation therapy - recent experience of a single centre. Kardiol Pol. 2010; 68(8): 903–909.
  8. McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007; 297(22): 2502–2514.
  9. Biffi M, Exner DV, Crossley GH, et al. Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site. Europace. 2013; 15(1): 77–82.
  10. Biffi M, Bertini M, Ziacchi M, et al. Management of phrenic stimulation in CRT patients over the long term: still an unmet need ? Pacing Clin Electrophysiol. 2011; 34(10): 1201–1208.
  11. Benkemoun H, Pons M, Kubler L, et al. Bipolar leads for prevention of phrenic nerve stimulation: results from the ORPHEE observational study. World J Cardiovasc Dis. 2017; 07(10): 323–331.
  12. Oswald H, Asbach S, Köbe J, et al. Effectiveness and reliability of selected site pacing for avoidance of phrenic nerve stimulation in CRT patients with quadripolar LV leads: the EffaceQ Study. Pacing Clin Electrophysiol. 2015; 38(8): 942–950.
  13. Crossley GH, Biffi M, Johnson B, et al. Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study. Heart Rhythm. 2015; 12(4): 751–758.
  14. Forleo GB, Di Biase L, Della Rocca DG, et al. Impact of previous myocardial infarction on outcomes of CRT patients implanted with a quadripolar left ventricular lead. Results from a multicentric prospective study. Int J Cardiol. 2012; 160(2): 145–146.
  15. Asbach S, Hartmann M, Wengenmayer T, et al. Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial. PLoS One. 2013; 8(6): e67235.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl